$RVXCF up over 20% this week so far.... Not as
Post# of 98051
Not as good as what a sub penny stock does of course...Phase III clinical trial of Diabetes patients on going for 2 years now, planned trials for Fabrys disease and Chronic Kidney Disease as well....Apabetalone could be a blockbuster.